John White

Mr. White is a partner in the law firm Cooper & Dunham LLP that specializes in intellectual property law.

Mr. White’s law practice primarily focuses on the areas of pharmaceuticals, biotechnology, and medical devices representing corporations, start-up ventures and university research centers in counseling, patent prosecution, licensing and litigation.

Mr. White has served on the boards of directors of a number of successful start-up ventures, which became public companies, including Bio-Technology General Corporation (now Savient Pharmaceuticals), IGEN, Inc. (acquired by Roche), TCell Sciences, Inc. (acquired by Biogen/Idec), and OSI Pharmaceuticals, Inc., which was recently acquired by Astellas.

Mr. White attended Columbia University School of Engineering, where he earned a B.S. degree in chemical engineering, and Columbia University’s School of Graduate Arts and Sciences where he earned an M.A. degree in chemical biology and a M.Ph. degree in biophysical chemistry. Mr. White also received a J.D. degree from Fordham University.